vimarsana.com

Latest Breaking News On - Xponential fitness company profile - Page 7 : vimarsana.com

Xponential Fitness (NYSE:XPOF) Announces Earnings Results

Xponential Fitness (NYSE:XPOF – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.13), Briefing.com reports. Xponential Fitness had a negative net margin of 0.20% and a negative return on equity of 19.44%. The business had revenue of […]

Insider Selling: Xponential Fitness, Inc (NYSE:XPOF) CEO Sells $1,022,369 85 in Stock

Xponential Fitness, Inc. (NYSE:XPOF – Get Rating) CEO Anthony Geisler sold 30,785 shares of the company’s stock in a transaction dated Monday, May 1st. The stock was sold at an average price of $33.21, for a total transaction of $1,022,369.85. Following the completion of the transaction, the chief executive officer now owns 375,848 shares in […]

Insider Selling: Xponential Fitness, Inc (NYSE:XPOF) CEO Sells 81,570 Shares of Stock

Xponential Fitness, Inc. (NYSE:XPOF – Get Rating) CEO Anthony Geisler sold 81,570 shares of the firm’s stock in a transaction on Wednesday, April 19th. The stock was sold at an average price of $32.83, for a total value of $2,677,943.10. Following the completion of the transaction, the chief executive officer now directly owns 443,479 shares […]

Xponential Fitness (NYSE:XPOF) Sets New 1-Year High at $32 25

Xponential Fitness, Inc. (NYSE:XPOF – Get Rating)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $32.25 and last traded at $31.89, with a volume of 105995 shares trading hands. The stock had previously closed at $31.33. Analyst Upgrades and Downgrades Several equities analysts recently commented […]

Xponential Fitness (NYSE:XPOF) Coverage Initiated at Lake Street Capital

Lake Street Capital assumed coverage on shares of Xponential Fitness (NYSE:XPOF – Get Rating) in a report published on Monday, MarketBeat Ratings reports. The firm issued a buy rating and a $38.00 price target on the stock. XPOF has been the topic of several other research reports. Morgan Stanley raised their price objective on Xponential […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.